Scientists at NYU Abu Dhabi have developed an innovative use for nanotechnology in the field of cancer research. Their ...

Multiple myeloma, a cancer of the bone marrow, remains difficult to treat despite modern CAR T cell therapies. In recent research, a team led by Dr. Armin Rehm presents an improved immunotherapy that ...

Cancer is one of the causes responsible for the most deaths worldwide. In 2020, for example, it resulted in ten million ...

A groundbreaking phase 2 trial explores a novel, chemotherapy-free immunotherapy for relapsed indolent B-cell lymphomas, aiming to enhance patient outcomes.

Scientists in South Korea have discovered that one of the most common malignant brain tumors in young adults may begin years ...

Dr. Myron Czuczman highlighted the significance of the recent U.S. Food and Drug Administration (FDA) approval of Lymphir ...

Single-cell technologies uncover how leukemia cells evolve, resist therapy, and survive through cell-to-cell communication.

Cancer’s deadliest talent is not rapid growth but the ability to sidestep the internal programs that should make damaged cells self-destruct. Across multiple labs, researchers are now converging on a ...

How this fungus influences the development of melanoma cells has for the first time been explained by the MicrobiomicsEHU ...